Hepatitis B vaccine linked with a lower risk of developing diabetes
Scientists have previously found the vaccine appears to cut the risk of diabetes. This may be due to the hepatitis B virus – which infects the liver and spreads through blood, semen and vaginal fluids – disrupting the organ’s ability to store sugar from the blood. This could raise the risk of diabetes, where blood sugar levels are persistently too high. But prior studies have not looked at whether the vaccine might reduce diabetes risk among a group of both immunised and non-immunised people who haven’t contracted hepatitis B, which would suggest the effect acts independently of just preventing the infection. To explore this, Nhu-Quynh Phan at Taipei Medical University in Taiwan and her colleagues analysed the health records of more than 580,000 people living across the US, Europe, Africa, Latin America, the Middle East and the Asia-Pacific. On average, these records spanned nearly four years for each individual between 2005 and 2023. Indian Scientist Awards 2025! Visit: https://ind...